Table 2.
Change in outcome variables pre and post intervention.
| Pre | Post | Pre–Post change | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean diff. | % impro. | ES | CSC | ||
| Pain Int. | OPMP | 7.3 | 1.8 | 5.7 | 2 | 1.6 | 22% | 0.9 | 48% |
| F2F PMP | 7.4 | 2 | 5.1 | 2.3 | 2.3 | 28% | 1.1 | 58% | |
| Pain Di. | OPMP | 7.1 | 1.6 | 5.3 | 2.1 | 1.8 | 26% | 1 | 53% |
| F2F PMP | 7.5 | 1.4 | 6.5 | 1.8 | 1 | 13% | 0.7 | 32% | |
| PCS | OPMP | 29.1 | 9.9 | 21.2 | 11.2 | 7.9 | 27% | 0.8 | 43% |
| F2F PMP | 30.4 | 11.1 | 19 | 12.1 | 11.4 | 36% | 1 | 48% | |
| PSEQ | OPMP | 16.3 | 10.2 | 28.2 | 12.6 | −11.9 | 73% | 1.2 | 50% |
| F2F PMP | 17.8 | 9.5 | 31.4 | 11.3 | −13.8 | 77% | 1.5 | 59% | |
| BDI-II | OPMP | — | — | — | — | — | — | — | — |
| F2F PMP | 26.9 | 10.8 | 17.5 | 11.5 | 9.3 | 35% | 0.9 | 43% | |
| PHQ-9 | OPMP | 14.1 | 5.1 | 10 | 5 | 4.1 | 29% | 0.8 | 35% |
| F2F PMP | — | — | — | — | — | — | — | — | |
| STS | OPMP | 4.9 | 5.1 | 9.5 | 7.5 | −4.6 | 95% | 0.9 | 42% |
| F2F PMP | 5.7 | 5.5 | 9.7 | 5.4 | −4 | 71% | 0.7 | 32% | |
| COPM-P | OPMP | — | — | — | — | — | — | — | — |
| F2F PMP | 2.9 | 1.7 | 5.8 | 1.6 | 2.9 | 100% | 2.46 | 76% | |
| COPM-S | OPMP | — | — | — | — | — | — | — | — |
| F2F PMP | 2.1 | 1.2 | 5.6 | 2 | 3.5 | 167% | 3.12 | 86% | |
| PSFS | OPMP | 2.8 | 1.3 | 5.8 | 1.5 | 3 | 107% | 2.3 | 91% |
| F2F PMP | — | — | — | — | — | — | — | — | |
Mean Diff., mean difference; % impro., percent improvement; ES, effect size; CSC, clinically significant change; Pain int, pain intensity; Pain di, pain distress; PCS, pain catastrophising scale; PSEQ, pain self-efficacy questionnaire; BDI-II, Beck depression inventory II; PHQ-9, patient health questionnaire; STS, sit to stand; COPM-P, Canadian occupational performance measure-performance; COPM-S, Canadian occupational performance measure-satisfaction; PSFS, patient-specific functional scale.